cefoperazone has been researched along with cefuroxime in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (41.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eichenwald, HF | 1 |
| Bosso, JA; Marble, DA; Townsend, RJ | 1 |
| Brenciaglia, MI; Cipriani, P; Filadoro, F; Ghezzi, MC; Giordano, A; Mancini, C; Rivanera, D | 1 |
| Concia, E; Marino, P; Marone, P; Verani, D | 1 |
| Iegri, F; Lorenzi, A; Mascellino, MT; Prignano, G | 1 |
| Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
| Garcia-Rodriguez, JA | 1 |
| Durosoir, JL; Saliou, P; Thabaut, A | 1 |
| Forsgren, A | 1 |
| Grimm, L; McCracken, GH; Nelson, JD | 1 |
| Frongillo, RF; Galuppo, L; Moretti, A | 1 |
| Carson, M; Miles, HM; Pavillard, ER | 1 |
| Chen, D; Song, Z; Wang, Z | 1 |
| Cankaya, M; Coban, TA; Ekinci, D; Gül, İ | 1 |
| Beydemir, Ş; Şengül, B | 1 |
| Gülçin, İ; Huyut, Z; Taslimi, P; Türkan, F | 1 |
| Calimli, MH; Huyut, MT; Huyut, Z; Türkan, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM | 1 |
| Hsiao, YJ; Hu, RM; Huang, KJ; Wu, LT; Yang, TC | 1 |
| Arpin, C; Fournier, M; Gagné, S; Hernould, M; Quentin, C | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP | 1 |
| de Waart, DR; Duijst, S; Kunne, C; Oude Elferink, RP; Paulusma, CC; van de Wetering, K | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cefoperazone and cefuroxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
28 other study(ies) available for cefoperazone and cefuroxime
| Article | Year |
|---|---|
Bacterial meningitis: is there a "best" antimicrobial therapy?
Topics: Cefoperazone; Ceftazidime; Ceftriaxone; Cefuroxime; Cephalosporins; Child; Humans; Infant, Newborn; Meningitis; Meningitis, Haemophilus; Moxalactam | 1987 |
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
Topics: Aztreonam; Cefamandole; Cefonicid; Cefoperazone; Cefuroxime; Cephalosporins; Clindamycin; Drug Combinations; Drug Incompatibility; Drug Packaging; Drug Stability; Syringes | 1988 |
In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin.
Topics: Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephaloridine; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1984 |
[Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephacetrile; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cephradine; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Salmonella; Staphylococcus aureus | 1982 |
[Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Topics: Acinetobacter; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus | 1982 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
Topics: Cefoperazone; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1980 |
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Topics: Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Neisseria meningitidis | 1981 |
Comparative in vitro activity of first, second and third generation cephalosporins.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Structure-Activity Relationship | 1981 |
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Infusions, Parenteral; Kinetics; Male; Meningitis, Haemophilus; Meningitis, Pneumococcal; Moxalactam; Rabbits; Streptococcus pneumoniae | 1982 |
Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method.
Topics: Adult; Aged; Blister; Body Fluids; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Female; Humans; Kinetics; Male; Middle Aged; Skin; Tissue Distribution | 1983 |
Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefoxitin; Cefuroxime; Cephalosporins; Drug Synergism; Microbial Sensitivity Tests; Ticarcillin | 1981 |
Study on the binding behavior of bovine serum albumin with cephalosporin analogues by chemiluminescence method.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefaclor; Cefadroxil; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Luminescence; Luminescent Measurements; Phthalic Acids; Serum Albumin, Bovine; Thermodynamics; Tryptophan | 2010 |
Susceptibility of cord blood antioxidant enzymes glutathione reductase, glutathione peroxidase and glutathione S-transferase to different antibiotics: in vitro approach.
Topics: Anti-Bacterial Agents; Antioxidants; Cefoperazone; Ceftizoxime; Ceftriaxone; Cefuroxime; Dose-Response Relationship, Drug; Erythrocytes; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Humans; Molecular Structure; Structure-Activity Relationship | 2013 |
The interactions of cephalosporins on polyol pathway enzymes from sheep kidney.
Topics: Aldehyde Reductase; Animals; Anti-Bacterial Agents; Cefazolin; Cefoperazone; Ceftazidime; Ceftriaxone; Cefuroxime; Cephalosporins; Enzyme Activation; Enzyme Inhibitors; Glyceraldehyde; Hydrogen-Ion Concentration; Kidney; Kinetics; L-Iditol 2-Dehydrogenase; Models, Molecular; Sheep; Sorbitol; Temperature | 2018 |
The in vivo effects of cefazolin, cefuroxime, and cefoperazon on the carbonic anhydrase in different rat tissues.
Topics: Animals; Carbonic Anhydrases; Cefazolin; Cefoperazone; Cefuroxime; Organ Specificity; Rats | 2018 |
In vivo biochemical evaluations of some β-lactam group antibiotics on glutathione reductase and glutathione S- transferase enzyme activities.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Cefoperazone; Cefuroxime; Cephalosporins; Enzyme Inhibitors; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Rats | 2019 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA | 2007 |
Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catechol 2,3-Dioxygenase; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Stenotrophomonas maltophilia | 2008 |
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
Topics: Aeromonas hydrophila; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Dipeptides; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Substrate Specificity | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin | 2010 |
Oral availability of cefadroxil depends on ABCC3 and ABCC4.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Biological Transport; Cefadroxil; Cell Membrane; Enterocytes; Estradiol; Intestinal Absorption; Intestinal Mucosa; Jejunum; Mice; Mice, Knockout; Multidrug Resistance-Associated Proteins | 2012 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |